Press ReleasesCantourage Partners With FarmaGrowers To Bring The First South...

Cantourage Partners With FarmaGrowers To Bring The First South African Medical Cannabis To Germany


EUROPEAN medical cannabis leaders Cantourage and South Africa-based farming enterprise FarmaGrowers have confirmed an agreement to supply South African medical cannabis dried flower products to German pharmacies.

Cantourage partners with FarmaGrowers to bring the first South African medical cannabis to Germany

The agreement means that Germany’s growing number of currently more than 128,000 patients will now have access to South African medical cannabis dried flower products for the first time.

Since June 2021, Cantourage has used its Fast Track Access Platform to introduce medical cannabis strains from both Jamaica and Uruguay to German pharmacies. The platform involves use of a proprietary large-scale process to reduce microbial load of imported cannabis without the use of irradiation – thereby securing continuous product supply while maintaining the natural terpene profile of the medical cannabis products.

The new South African product is cultivated in FarmaGrowers’ controlled-environment indoor facilities, created by South African crop management supplier GreenZone. FarmaGrowers further enhances its medical cannabis production through the application of AEtrium, a sensor-driven, soil-free plant growth system from Californian agricultural supplier AEssense Corporation.

Philip Schetter, CEO of Cantourage, commented: “Our partnership with FarmaGrowers is a really key milestone and Cantourage is proud to be able to bring African medical cannabis to Germany. We have been working hard since the launch of our new platform in June to ensure that the European market can be quickly opened up to new types of products that can potentially offer new and broader benefits to patients in Germany and throughout the EU. We would like to thank NICE Partners for helping to establish our partnership with FarmaGrowers.”

Mario Marais, Executive Director and co-founder of FarmaGrowers, added: “FarmaGrowers has worked exceptionally hard over the past few years to develop high-quality medical cannabis using sustainable cultivation methods. We are extremely excited to be able to bring these products to patients and pharmacies in Europe thanks to our collaboration with Cantourage. We look forward to strengthening the relationship and helping to ensure that growing numbers of patients throughout Germany can have their needs met with product from South Africa”.

Established in 2019 in Brits, a rural town in the South African province of North West, family-owned FarmaGrowers specializes in the cultivation, manufacture and export of medicinal cannabis. FarmaGrowers leverages South Africa’s mild, sunny, seasonal climate and high average daily hours of sunlight to produce high-quality and environmentally sustainable medical cannabis.

About Cantourage GmbH

Cantourage is a leading European medical cannabis company. The Berlin-based company was founded in 2019 by industry pioneers Dr Florian Holzapfel, Norman Ruchholtz and Patrick Hoffman. Cantourage enables producers from across the world to bring their product into the growing and profitable European market more quickly and cheaply, while guaranteeing and further developing highest European quality standards. It offers products in all relevant market segments: dried flowers, extracts and Dronabinol.

About FarmaGrowers

A large family-owned vegetable farming enterprise located in Brits, South Africa. FarmaGrowers is now also a globally certified GMP and GACP production supplier of medicinal cannabis for global customers. FarmaGrowers’ introduction video is available here. For more information, visit:

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.


Please enter your comment!
Please enter your name here

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

European Cannabis Market Leader Bloomwell Group Secures $10m Investment

The Bloomwell Group has successfully closed a seed funding round of over $10 million dollars—the highest publicly known seed investment...

German Hemp Farm Numbers Up 900% In Seven Years – As industry Calls For Post-Election Reform

THE number of German farms growing industrial hemp has hit 863 – the highest figure since the federal republic...

US Company Set To Launch UK Medical Cannabis Study In Partnership With Manchester University

A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...

You might also likeRELATED
Recommended to you